November 17, 2014 / SCAI Statement
A new study presented today looks at the risks and benefits of continuing dual antiplatelet therapy beyond one year after placement of one or more drug-eluting stents as compared with aspirin therapy alone. The DAPT study’s authors conclude that, while continuing dual antiplatelet therapy with a thienopyridine (clopidogrel or prasugrel) in addition to aspirin after one year significantly reduced the risks of stent thrombosis and major adverse cardiovascular and cerebrovascular events, continuation was also associated with increased risk of bleeding. Read the Statement.
November 10, 2014 / President's Message
Last week a team of SCAI advocates convinced Oregon’s Health Evidence Review Commission (HERC) that its initial draft coverage policy on treating stable angina requires significant revision before it can be considered for implementation. If the draft policy had been implemented, it would have been extremely restrictive, ultimately denying one-third of Oregon’s citizens access to evidence-based care of their stable angina. Read the Message.
November 4, 2014 / Press Release
Once a common procedure, left ventriculography’s role in assessing heart disease has evolved considerably over the decades, leading to significant variations in use. A new expert consensus statement e-published today by the Society for Cardiovascular Angiography and Interventions (SCAI) recommends optimal uses for left ventriculography, with the goal of more standardized use of the test and improved quality of care for cardiac patients. Find Out More.
October 2, 2014 / CCI - includes video
CCI Editor-in-Chief, Steven R. Bailey, MD, MSCAI discusses the 84:4 (1 October 2014) CCI Editor's Choice article with article co-author Femi Philip, MD. Watch the Interview and Access the Article.
October 1, 2014 / Press Release
New updates to the Society for Cardiovascular Angiography and Interventions’ (SCAI) highly regarded appropriate use criteria (AUC) calculator tool will help healthcare providers in making treatment decisions for patients who are candidates for diagnostic catheterization or imaging for heart failure. The updated tool – available online or through an iOS and Android app – is available for download today. Find Out More.